Getting More From Results
Cancer is one of the leading causes of death in the modern age, second only to HIV/AIDS. In 2014 alone, of an estimated 2,598,970 deaths around the world, 585,720 were attributed to cancer while an additional 1,665,540 new cases were reported. In addition, the WHO’s 2014 World Cancer Report estimates that the number of new cases per year is expected to rise to 22 million within the next 20 years.
Clinical trials are also expanding, a process which is central to the development of new treatments and diagnostic tools that could potentially save lives. Unfortunately, the returns on this type of medical research is hindered by two main issues: one, the rate at which medical advancement takes place is beginning to outpace our ability to test those advancements. And two, far too few patients are taking part in clinical trials, which is crucial when assessing which new treatments are effective and which ones are not.
If the situation is to be remedied, an environment needs to be fostered where information is more readily available and involvement is encouraged. This is where the Clinical Trial Innovation Prize comes into play. Funded by the Bonnie J. Addario Lung Cancer Foundation and Free to Breathe, this incentive-based competition is designed to produce a breakthrough that will effectively double the accrual rate of clinical trials in the diagnosis and treatment of cancer, improving life expectancy and quality of life for those with the disease.